Association between PCSK9 and LDLR gene polymorphisms with coronary heart disease: Case-control study and meta-analysis

Clinical Biochemistry

Volumn 46, Issue 9, 2013, Pages 727-732

  Zhang, Lina ^a   Yuan, Fang ^a   Liu, Panpan ^a   Fei, Lijuan ^a   Huang, Yi ^a   Xu, Limin ^a   Hao, Lingmei ^b   Qiu, Xujun ^b   Le, Yanping ^a   Yang, Xi ^a   Xu, Weifeng ^a   Huang, Xiaoyan ^a   Ye, Meng ^a   Zhou, Jianqing ^a   Lian, Jiangfang ^a   Duan, Shiwei ^a  

^a NINGBO UNIVERSITY   (China)

^b Seventh Hospital of Ningbo   (China)

Author keywords

LDL C; LDLR; Meta analysis; PCSK9; SNP

Indexed keywords

KEXIN TYPE SERINE PROTEASE 9; LOW DENSITY LIPOPROTEIN RECEPTOR; PROTEINASE; UNCLASSIFIED DRUG;

ARTICLE; CASE CONTROL STUDY; CAUCASIAN; GENOTYPE; HUMAN; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; SYSTEMATIC REVIEW;

AGED; CASE-CONTROL STUDIES; CORONARY DISEASE; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PROPROTEIN CONVERTASES; RECEPTORS, LDL; RISK FACTORS; SEQUENCE ANALYSIS, DNA; SERINE ENDOPEPTIDASES;

EID: 84877793925     PISSN: 00099120     EISSN: 18732933     Source Type: Journal    
DOI: 10.1016/j.clinbiochem.2013.01.013     Document Type: Article

References (28)

1. Lopez A.D., Mathers C.D., Ezzati M., Jamison D.T., Murray C.J. Global and regional burden of disease and risk factors, 2001: systematic analysis of population health data. Lancet 2006, 9524:1747-1757.
2. Marenberg M.E., Risch N., Berkman L.F., Floderus B., de Faire U. Genetic susceptibility to death from coronary heart disease in a study of twins. N Engl J Med 1994, 15:1041-1046.
3. Zdravkovic S., Wienke A., Pedersen N.L., Marenberg M.E., Yashin A.I., De Faire U. Heritability of death from coronary heart disease: a 36-year follow-up of 20966 Swedish twins. J Intern Med 2002, 3:247-254.
4. Kuulasmaa K., Tunstall-Pedoe H., Dobson A., Fortmann S., Sans S., Tolonen H., et al. Estimation of contribution of changes in classic risk factors to trends in coronary-event rates across the WHO MONICA Project populations. Lancet 2000, 9205:675-687.
5. Teslovich T.M., Musunuru K., Smith A.V., Edmondson A.C., Stylianou I.M., Koseki M., et al. Biological, clinical and population relevance of 95 loci for blood lipids. Nature 2010, 7307:707-713.
6. Third report of the National Cholesterol Education Program (NCEP) Expert Panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002, 25:3143-3421.
7. Chen Z., Peto R., Collins R., MacMahon S., Lu J., Li W. Serum cholesterol concentration and coronary heart disease in population with low cholesterol concentrations. Br Med J 1991, 6797:276-282.
8. Cohen J.C., Boerwinkle E., Mosley T.H., Hobbs H.H. Sequence variations in PCSK9, low LDL, and protection against coronary heart disease. N Engl J Med 2006, 12:1264-1272.
9. Seidah N.G., Benjannet S., Wickham L., Marcinkiewicz J., Jasmin S.B., Stifani S., et al. The secretory proprotein convertase neural apoptosis-regulated convertase 1 (NARC-1): liver regeneration and neuronal differentiation. Proc Natl Acad Sci U S A 2003, 3:928-933.
10. Tibolla G., Norata G.D., Artali R., Meneghetti F., Catapano A.L. Proprotein convertase subtilisin/kexin type 9 (PCSK9): from structure-function relation to therapeutic inhibition. Nutr Metab Cardiovasc Dis 2011, 11:835-843.
11. Huijgen R., Boekholdt S.M., Arsenault B.J., Bao W., Davaine J.M., Tabet F., et al. Plasma PCSK9 levels and clinical outcomes in the TNT (Treating to New Targets) trial: a nested case-control study. J Am Coll Cardiol 2012, 20:1778-1784.
12. Kathiresan S., Voight B.F., Purcell S., Musunuru K., Ardissino D., Mannucci P.M., et al. Genome-wide association of early-onset myocardial infarction with single nucleotide polymorphisms and copy number variants. Nat Genet 2009, 3:334-341.
13. Reilly M.P., Li M., He J., Ferguson J.F., Stylianou I.M., Mehta N.N., et al. Identification of ADAMTS7 as a novel locus for coronary atherosclerosis and association of ABO with myocardial infarction in the presence of coronary atherosclerosis: two genome-wide association studies. Lancet 2011, 9763:383-392.
14. Willer C.J., Sanna S., Jackson A.U., Scuteri A., Bonnycastle L.L., Clarke R., et al. Newly identified loci that influence lipid concentrations and risk of coronary artery disease. Nat Genet 2008, 2:161-169.
15. Schunkert H., Konig I.R., Kathiresan S., Reilly M.P., Assimes T.L., Holm H., et al. Large-scale association analysis identifies 13 new susceptibility loci for coronary artery disease. Nat Genet 2011, 4:333-338.
16. Xu C., Wang F., Wang B., Li X., Li C., Wang D., et al. Minor allele C of chromosome 1p32 single nucleotide polymorphism rs11206510 confers risk of ischemic stroke in the Chinese Han population. Stroke 2010, 8:1587-1592.
17. Lv X., Zhang Y., Rao S., Qiu J., Wang M., Luo X., et al. Joint effects of genetic variants in multiple loci on the risk of coronary artery disease in Chinese Han subjects. Circ J 2012.
18. Matsumura K., Okuda Y., Ito T., Hirano T., Takeda K., Yamaguchi N. Coronary angiography of Kawasaki disease with the coronary vasodilator dipyridamole: assessment of distensibility of affected coronary arterial wall. Angiology 1988, 2:141-147.
19. Excoffier L., Laval G., Schneider S. Arlequin (version 3.0): an integrated software package for population genetics data analysis. Evol Bioinform Online 2005, 47-50.
20. Engels E.A., Schmid C.H., Terrin N., Olkin I., Lau J. Heterogeneity and statistical significance in meta-analysis: an empirical study of 125 meta-analyses. Stat Med 2000, 13:1707-1728.
21. Ioannidis J.P., Patsopoulos N.A., Evangelou E. Heterogeneity in meta-analyses of genome-wide association investigations. PLoS One 2007, 9:e841.
22. Waterworth D.M., Ricketts S.L., Song K., Chen L., Zhao J.H., Ripatti S., et al. Genetic variants influencing circulating lipid levels and risk of coronary artery disease. Arterioscler Thromb Vasc Biol 2010, 11:2264-2276.
23. Guella I., Asselta R., Ardissino D., Merlini P.A., Peyvandi F., Kathiresan S., et al. Effects of PCSK9 genetic variants on plasma LDL cholesterol levels and risk of premature myocardial infarction in the Italian population. J Lipid Res 2010, 11:3342-3349.
24. Qi L., Parast L., Cai T., Powers C., Gervino E.V., Hauser T.H., et al. Genetic susceptibility to coronary heart disease in type 2 diabetes: 3 independent studies. J Am Coll Cardiol 2011, 25:2675-2682.
25. Martinelli N., Girelli D., Lunghi B., Pinotti M., Marchetti G., Malerba G., et al. Polymorphisms at LDLR locus may be associated with coronary artery disease through modulation of coagulation factor VIII activity and independently from lipid profile. Blood 2010, 25:5688-5697.
26. Kathiresan S., Manning A.K., Demissie S., D'Agostino R.B., Surti A., Guiducci C., et al. A genome-wide association study for blood lipid phenotypes in the Framingham Heart Study. BMC Med Genet 2007, S17.
27. Kathiresan S., Willer C.J., Peloso G.M., Demissie S., Musunuru K., Schadt E.E., et al. Common variants at 30 loci contribute to polygenic dyslipidemia. Nat Genet 2009, 1:56-65.
28. Doria A. Genetics of diabetes complications. Curr Diab Rep 2010, 6:467-475.